These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 9453017

  • 1. Quantitative studies of human urinary excretion of uropontin.
    Min W, Shiraga H, Chalko C, Goldfarb S, Krishna GG, Hoyer JR.
    Kidney Int; 1998 Jan; 53(1):189-93. PubMed ID: 9453017
    [Abstract] [Full Text] [Related]

  • 2. Contribution of human uropontin to inhibition of calcium oxalate crystallization.
    Asplin JR, Arsenault D, Parks JH, Coe FL, Hoyer JR.
    Kidney Int; 1998 Jan; 53(1):194-9. PubMed ID: 9453018
    [Abstract] [Full Text] [Related]

  • 3. Uropontin in urinary calcium stone formation.
    Hoyer JR.
    Miner Electrolyte Metab; 1994 Jan; 20(6):385-92. PubMed ID: 7783701
    [Abstract] [Full Text] [Related]

  • 4. [Role of uropontin in calcium oxalate lithogenesis].
    Paulhac P, Desgrandchamps F, Dumas JP, Teillac P, Le Duc A, Colombeau P.
    Prog Urol; 2002 Feb; 12(1):114-7. PubMed ID: 11980003
    [Abstract] [Full Text] [Related]

  • 5. Effects of microgravity on urinary osteopontin.
    Hoyer JR, Pietrzyk RA, Liu H, Whitson PA.
    J Am Soc Nephrol; 1999 Nov; 10 Suppl 14():S389-93. PubMed ID: 10541270
    [Abstract] [Full Text] [Related]

  • 6. Inhibition of calcium oxalate crystal growth in vitro by uropontin: another member of the aspartic acid-rich protein superfamily.
    Shiraga H, Min W, VanDusen WJ, Clayman MD, Miner D, Terrell CH, Sherbotie JR, Foreman JW, Przysiecki C, Neilson EG.
    Proc Natl Acad Sci U S A; 1992 Jan 01; 89(1):426-30. PubMed ID: 1729712
    [Abstract] [Full Text] [Related]

  • 7. [Sodium excretion in children with lithogenic disorders].
    Kovacević L, Kovacević S, Smoljanić Z, Peco-Antić A, Kostić N, Gajić M, Kovacević N, Jovanović O.
    Srp Arh Celok Lek; 1998 Jan 01; 126(9-10):321-6. PubMed ID: 9863402
    [Abstract] [Full Text] [Related]

  • 8. Urinary calcium oxalate crystal growth inhibitors.
    Worcester EM.
    J Am Soc Nephrol; 1994 Nov 01; 5(5 Suppl 1):S46-53. PubMed ID: 7873744
    [Abstract] [Full Text] [Related]

  • 9. Changes in urinary stone risk factors in hypocitraturic calcium oxalate stone formers treated with dietary sodium supplementation.
    Stoller ML, Chi T, Eisner BH, Shami G, Gentle DL.
    J Urol; 2009 Mar 01; 181(3):1140-4. PubMed ID: 19152919
    [Abstract] [Full Text] [Related]

  • 10. [Uronic-acid-rich protein: a new glycoprotein inhibiting the crystallization of calcium oxalate in vitro].
    Atmani F, Lacour B, Daudon M.
    Nephrologie; 1996 Mar 01; 17(3):157-62. PubMed ID: 9064564
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Role of the diurnal variation of urinary pH and urinary calcium in urolithiasis: a study in outpatients.
    Murayama T, Sakai N, Yamada T, Takano T.
    Int J Urol; 2001 Oct 01; 8(10):525-31; discussion 532. PubMed ID: 11737477
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Inhibitors of stone formation.
    Worcester EM.
    Semin Nephrol; 1996 Sep 01; 16(5):474-86. PubMed ID: 8890402
    [Abstract] [Full Text] [Related]

  • 16. Intracrystalline proteins and urolithiasis: a comparison of the protein content and ultrastructure of urinary calcium oxalate monohydrate and dihydrate crystals.
    Ryall RL, Chauvet MC, Grover PK.
    BJU Int; 2005 Sep 01; 96(4):654-63. PubMed ID: 16104927
    [Abstract] [Full Text] [Related]

  • 17. Seasonal variations in urinary risk factors among patients with nephrolithiasis.
    Stuart RO 2nd, Hill K, Poindexter J, Pak CY.
    J Lithotr Stone Dis; 1991 Jan 01; 3(1):18-27. PubMed ID: 11536932
    [Abstract] [Full Text] [Related]

  • 18. Ultrastructural immunodetection of osteopontin and osteocalcin as major matrix components of renal calculi.
    McKee MD, Nanci A, Khan SR.
    J Bone Miner Res; 1995 Dec 01; 10(12):1913-29. PubMed ID: 8619372
    [Abstract] [Full Text] [Related]

  • 19. Insulin resistance and low urinary citrate excretion in calcium stone formers.
    Cupisti A, Meola M, D'Alessandro C, Bernabini G, Pasquali E, Carpi A, Barsotti G.
    Biomed Pharmacother; 2007 Jan 01; 61(1):86-90. PubMed ID: 17184967
    [Abstract] [Full Text] [Related]

  • 20. The influence of dietary factors on the risk of urinary stone formation.
    Hesse A, Siener R, Heynck H, Jahnen A.
    Scanning Microsc; 1993 Sep 01; 7(3):1119-27; discussion 1127-8. PubMed ID: 8146611
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.